According to information from NDR 90.3, the active ingredient was injected into a test person for the first time last Friday. The UKE does not want to reveal much about it yet – it is still too early for that because the vaccination study has only just begun. The researchers do not want to raise unnecessarily high expectations. But: So far everything is going according to plan.
Phase 1: how safe is the vaccine?
The first test person was a woman who – like many others – had volunteered at the UKE. Because she was the first, she was only given a low dose of the active ingredient just to be on the safe side. It wasn’t until 24 hours later that the next two test subjects had their turn. The active ingredient has now been injected into six of the 30 participants. The first phase of the vaccination study is about finding out how safe and tolerable the vaccine is and whether the immune system reacts to the vaccine at all.
Third approved corona vaccination study in Germany
If this first run is successful, the vaccine will be tested in two further phases. This could start at the end of the year. Only then can it be approved. The corona vaccination study at the UKE is the third that has been approved by the authorities in Germany. The vaccine was developed in Marburg by the German Center for Infection Research and a pharmaceutical company from Saxony-Anhalt.
The active ingredient is a so-called vector vaccine. It is based on viruses that are harmless to humans. They are supposed to smuggle parts of the genetic material of the coronavirus into human cells so that the immune system can develop antibodies. Marylyn Addo, Head of Infectious Diseases at UKE, heads the clinical trial as the investigator in charge.
Larger study is to follow
In the second, more extensive study phase, additional groups of test subjects – including older people – are to be included in the tests, explained Addo. In addition to the UKE, the university clinics in Tübingen, Marburg and Munich will also be involved in these studies.
*The article has been translated based on the content of Source link by https://www.ndr.de/nachrichten/hamburg/coronavirus/Corona-Impfstoff-am-UKE-erstmals-Menschen-injiziert,impfstoff236.html
. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!